Daily summary: US stocks mixed as stimulus saga continues

• European shares close higher on upbeat earnings

• Wall Street erase early gains and moves lower
• New record number of daily COVID-19 cases

 

European indices finished today's session higher thanks to upbeat earnings from carmakers and banks. Daimler AG lifted its full-year guidance and posted better-than expected quarterly figures while Renault is expecting positive cash flow from cars by the end of this year. Barclays reported that its consumer businesses made some profits and provisions against bad loans fell in the third quarter. Meanwhile, pandemic situation is getting worse - new record of almost 480 thousand new cases was reported on Thursday of which 200,000 cases have been reported in Europe.  On the economic data front, PMI figures showed Eurozone's private sector activity fell back into contraction territory last month due to sharp deterioration in the service sector. During today's session DAX 30 rose 0.8%, CAC40 added 1% and FTSE100 finished 1.3% higher.

US indices erased earlier gains and are trading lower as investors remain concerned about the progress of the stimulus bill negotiations. While House Speaker Nancy Pelosi remains optimistic that a stimulus can be reached, she also admitted that it may take a while for legislation to be written and signed. Meanwhile President Trump said today, that he does not want the aid deal to bail out Democratic states, according to Reuters. Mnuchin also reportedly said there are still “significant differences” between the two sides. On the corporate front, Intel's stock plunged over 10% on mixed quarterly results. On the data front flash Markit PMI data pointed out that US economy is slowly recovering. Investors also welcomed the fact that Gilead Sciences’ antiviral drug remdesivir was approved by the US Food and Drug Administration as a treatment for COVID-19 after the country reported more than 71,600 new cases on Thursday, nearing record highs set in July, according to Johns Hopkins University data.

 

U.S. crude futures fell 2.10%, while the international benchmark Brent contract dropped 1.95 %   as investors remain concerned that evergrowing number of  new COVID-19 cases will hurt fuel demand recovery. President Vladimir Putin announced yesterday that he was prepared to extend supply cuts as pandemic is surging in the US and Europe. Meanwhile Libya announced it could double its production levels within next 4 weeks, increasing concerns on the supply side. Elsewhere, gold futures are trading nearly flat at $1,903/oz, while silver is trading 0.66% lower around $24.58/oz.

NZDUSD – pair broke above the major resistance level at 0.6659 which is additionally strengthened by 50 SMA (green line). As long as the price sits above it, then resistance at 0.6770 may come into play. Source: xStation5

The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.